Your browser doesn't support javascript.
loading
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors.
Edeline, Julien; Crouzet, Laurence; Le Sourd, Samuel; Larible, Claire; Brunot, Angélique; Le Roy, Florence; Cattenoz, Catherine; Latournerie, Marianne; Gédouin, Daniel; Guillygomarc'h, Anne; Boucher, Eveline.
Affiliation
  • Edeline J; Medical Oncology Department, Centre Eugène Marquis, Av de la bataille Flandres Dunkerque, 35043, Rennes, France, j.edeline@rennes.unicancer.fr.
Cancer Chemother Pharmacol ; 75(1): 215-9, 2015 Jan.
Article in En | MEDLINE | ID: mdl-25477009

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Aging / Platelet Aggregation Inhibitors / Niacinamide / Carcinoma, Hepatocellular / Venous Thrombosis / Liver Neoplasms / Antineoplastic Agents Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Country/Region as subject: Europa Language: En Journal: Cancer Chemother Pharmacol Year: 2015 Document type: Article Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Aging / Platelet Aggregation Inhibitors / Niacinamide / Carcinoma, Hepatocellular / Venous Thrombosis / Liver Neoplasms / Antineoplastic Agents Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Country/Region as subject: Europa Language: En Journal: Cancer Chemother Pharmacol Year: 2015 Document type: Article Country of publication: Germany